ARCHIVES

NCI Plans Briefing Oct. 8 In St. Louis for SPORE Applicants

This article is from The Cancer Letter archive.

Vol. 17 No. 34 | August 23, 1991

Download PDF Visit The Full Archive

Related Articles

Provenge Met Criteria For Approval, Sponsor Says

May 1, 2009

Letter: Legal Fund Seeks Support For Fisher

March 3, 1995

ODAC To Advise FDA on First Biosimilars Application Jan. 7

December 19, 2014

ASCO, NCCS form cancer quality alliance.

November 11, 2005

Oblimersen Combination Improves CLL Survival

December 28, 2007

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006